Pharmaceuticals raises in Atlanta

0 pharmaceuticals companies in Atlanta filed in the last 90 days, against 1 in the 90 days before. The biggest raise on record here is ALIMERA SCIENCES INC at $12M.

Companies raising per week

Everything on record

Copy the list as CSV

What each filing says

Beyond the amount sold, each Form D on this list states the size of the offering, how many investors had bought in when it was filed, the date of the first sale and what was sold.

• Nutrivert Inc., Form D filed 2026-04-29: an offering of $6M, of which $2.37M was sold; 2 investors already in; first sale on 2026-04-10; securities offered: equity; incorporated in Delaware; revenue range not disclosed. (source)
• ABLi Therapeutics, Inc., Form D filed 2026-01-13: an offering of $1M, of which $1M was sold; 10 investors already in; first sale on 2025-09-15; securities offered: equity; incorporated in Delaware; revenue range not disclosed. (source)
• Inhibikase Therapeutics, Inc., Form D filed 2024-06-04: an offering of $8M, with nothing reported sold yet; 1 investor already in; first sale on 2024-05-20; securities offered: equity, options or warrants, securities to be acquired on exercise; incorporated in Delaware; revenue range not disclosed. (source)
• Phytest Diagnostics, LLC, Form D filed 2023-08-15: an offering of $330K, of which $330K was sold; 7 investors already in; first sale on 2023-08-01; securities offered: equity; incorporated in Delaware; revenue range not disclosed. (source)
• ALIMERA SCIENCES INC, Form D filed 2023-04-07: an offering of $27M, of which $12M was sold; 4 investors already in; first sale on 2023-03-24; securities offered: equity, options or warrants, securities to be acquired on exercise; incorporated in Delaware; revenue range $25,000,001 - $100,000,000. (source)
• Nutrivert Inc., Form D filed 2023-03-23: an offering of $2M, of which $1.50M was sold; 1 investor already in; first sale on 2023-03-08; securities offered: equity; incorporated in Delaware; revenue range not disclosed. (source)
• Inhibikase Therapeutics, Inc., Form D filed 2023-02-07: an offering of $4.20M, of which $4.20M was sold; 1 investor already in; first sale on 2023-01-27; securities offered: options or warrants, securities to be acquired on exercise; incorporated in Delaware; revenue range not disclosed. (source)

Other sectors in Atlanta

AI and software Business services Health care Biotech Retail and restaurants Manufacturing Energy and climate

Pharmaceuticals in other metros

Pittsburgh Washington, DC Boston Miami New York Northern New Jersey Denver and Boulder San Francisco Bay Area Orlando and Tampa San Diego Philadelphia Raleigh-Durham Los Angeles Houston Dallas-Fort Worth Chicago

How this list is built

Every company here filed a Form D with the SEC from this sector and metro. A Form D is the notice a company files when it sells shares or other securities without a public offering, so it catches seed rounds, small rounds and rounds that were never announced, alongside the large ones that make the news. Only new offerings by operating companies count: amendments, pooled investment funds, real estate vehicles and special purpose vehicles are left out, so each row is a company raising money for itself.

The amount shown is the total the filing reports as sold so far. Some filings report nothing sold yet; those rows show a dash and add nothing to the totals. "First filing" marks a company whose first Form D on record this is. Each company links to our page for the filing, or to the SEC's own copy, and the list can be copied as CSV for a spreadsheet.